Pages that link to "Q54174334"
Jump to navigation
Jump to search
The following pages link to Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. (Q54174334):
Displaying 50 items.
- New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies (Q26799580) (← links)
- Genetic loci of Streptococcus mitis that mediate binding to human platelets (Q30979473) (← links)
- Current classification of the oral streptococci (Q33545285) (← links)
- Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci (Q33700561) (← links)
- E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci. (Q33957980) (← links)
- Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. (Q33960926) (← links)
- PCR-Based methods for genotyping viridans group streptococci. (Q33962369) (← links)
- Evaluation of the PASCO strep plus broth microdilution antimicrobial susceptibility panels for testing Streptococcus pneumoniae and other Streptococcal species. (Q33966759) (← links)
- Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials (Q33972339) (← links)
- In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada (Q33977709) (← links)
- In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer (Q33981500) (← links)
- Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000. (Q34107331) (← links)
- Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study (Q34557760) (← links)
- Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae (Q35102420) (← links)
- In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood (Q35119461) (← links)
- In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients (Q35126797) (← links)
- Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections (Q35136236) (← links)
- Commensal streptococci serve as a reservoir for β-lactam resistance genes in Streptococcus pneumoniae. (Q35607860) (← links)
- Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of Turkey (Q36067125) (← links)
- Infections with viridans group streptococci in children with cancer (Q36858122) (← links)
- Antibiotic prophylaxis for patients with acute leukemia. (Q37071680) (← links)
- Molecular mechanisms of β-lactam resistance in Streptococcus pneumoniae (Q37990942) (← links)
- Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. (Q39472017) (← links)
- Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae (Q39473366) (← links)
- All detectable high-molecular-mass penicillin-binding proteins are modified in a high-level beta-lactam-resistant clinical isolate of Streptococcus mitis (Q39477794) (← links)
- Antimicrobial prospect of newly synthesized 1,3-thiazole derivatives. (Q39688569) (← links)
- Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience (Q40106977) (← links)
- A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation. (Q40451325) (← links)
- Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis. (Q40490160) (← links)
- Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors (Q40558579) (← links)
- Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients (Q40604155) (← links)
- Microbiological findings in febrile neutropenia (Q40612531) (← links)
- Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients (Q42218307) (← links)
- Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns (Q42288205) (← links)
- Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children (Q43562244) (← links)
- Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients (Q43723782) (← links)
- Infections caused by viridans streptococci in patients with neutropenia (Q43996926) (← links)
- Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States (Q44417864) (← links)
- Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases (Q44455735) (← links)
- Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid (Q44468683) (← links)
- Antimicrobial susceptibility of viridans group streptococci (Q44899345) (← links)
- Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci (Q44959765) (← links)
- [beta-Lactam antibiotics]. (Q53943304) (← links)
- Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. (Q54030467) (← links)
- Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group. (Q54105200) (← links)
- [What standpoint to take in regard to bacterial resistance to antibiotics in internal medicine]. (Q54121178) (← links)
- In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. (Q54135243) (← links)
- Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. (Q54590986) (← links)
- Daptomicina en las infecciones por bacterias grampositivas en pacientes oncohematológicos y en receptores de trasplante (Q58854029) (← links)
- Emerging problem pathogens: A review of resistance patterns over time (Q64136074) (← links)